Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COL-121 Ointment in Plaque-Type Psoriasis
NCT00625326Phase 2Completed
- Sponsor
- Deltanoid Pharmaceuticals
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of COL-121 in plaque psoriasis, sponsored by Deltanoid Pharmaceuticals. Started Jan 2008; status: completed.
02
Drugs
COL-121
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00625326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625326.